tranexamic acid has been researched along with Neoplasms in 17 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
" Several reports show a successful therapeutic use of the antifibrinolytic agent tranexamic acid in palliative care patients having hemorrhages." | 7.85 | Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid. ( Bardenheuer, HJ; Frankenhauser, S; Geist, MJP; Kessler, J, 2017) |
" In the present case study, a new technique, using intratumoral injection of tranexamic acid to control significant bleeding during bronchoscopic biopsy, is described." | 7.77 | Bronchoscopic intratumoral injection of tranexamic acid: a new technique for control of biopsy-induced bleeding. ( Zamani, A, 2011) |
"Many patients with cancer involving the respiratory system suffer from the frequent recurrence of significant, submassive hemoptysis, which may result in invasive procedures, hospital stays, and a reduction in quality of life." | 5.42 | Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis. ( Hankerson, MJ; Mallon, WK; Raffetto, B; Shoenberger, JM, 2015) |
" Several reports show a successful therapeutic use of the antifibrinolytic agent tranexamic acid in palliative care patients having hemorrhages." | 3.85 | Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid. ( Bardenheuer, HJ; Frankenhauser, S; Geist, MJP; Kessler, J, 2017) |
" In the present case study, a new technique, using intratumoral injection of tranexamic acid to control significant bleeding during bronchoscopic biopsy, is described." | 3.77 | Bronchoscopic intratumoral injection of tranexamic acid: a new technique for control of biopsy-induced bleeding. ( Zamani, A, 2011) |
" Secondary outcomes were other adverse events, blood transfusion, and blood loss." | 2.55 | The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis. ( Breau, RH; Cagiannos, I; Cnossen, S; Fergusson, DA; Fergusson, NA; Hutton, B; Lavallée, LT; Montroy, J; Morash, C, 2017) |
"Many patients with cancer involving the respiratory system suffer from the frequent recurrence of significant, submassive hemoptysis, which may result in invasive procedures, hospital stays, and a reduction in quality of life." | 1.42 | Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis. ( Hankerson, MJ; Mallon, WK; Raffetto, B; Shoenberger, JM, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 5 (29.41) | 24.3611 |
2020's | 6 (35.29) | 2.80 |
Authors | Studies |
---|---|
Lin, R | 1 |
Elf, S | 1 |
Shan, C | 1 |
Kang, HB | 1 |
Ji, Q | 1 |
Zhou, L | 1 |
Hitosugi, T | 1 |
Zhang, L | 1 |
Zhang, S | 1 |
Seo, JH | 1 |
Xie, J | 1 |
Tucker, M | 1 |
Gu, TL | 1 |
Sudderth, J | 1 |
Jiang, L | 1 |
Mitsche, M | 1 |
DeBerardinis, RJ | 1 |
Wu, S | 1 |
Li, Y | 1 |
Mao, H | 1 |
Chen, PR | 1 |
Wang, D | 1 |
Chen, GZ | 1 |
Hurwitz, SJ | 1 |
Lonial, S | 1 |
Arellano, ML | 1 |
Khoury, HJ | 1 |
Khuri, FR | 1 |
Lee, BH | 1 |
Lei, Q | 1 |
Brat, DJ | 1 |
Ye, K | 1 |
Boggon, TJ | 1 |
He, C | 1 |
Kang, S | 1 |
Fan, J | 1 |
Chen, J | 1 |
Gazendam, AM | 1 |
Schneider, P | 1 |
Vélez, R | 1 |
Ghert, M | 1 |
Ackerman, RS | 1 |
Hirschi, M | 1 |
Trona, N | 1 |
Joyce, DM | 1 |
Evans, T | 1 |
Patel, SY | 1 |
Wright, GP | 1 |
Wolf, AM | 1 |
Waldherr, TL | 1 |
Ritz-Holland, D | 1 |
Laney, ED | 1 |
Chapman, HA | 1 |
Lane, BR | 1 |
Assifi, MM | 1 |
Chung, MH | 1 |
Montroy, J | 2 |
Hutton, B | 2 |
Fergusson, DA | 2 |
Tinmouth, A | 1 |
Lavallée, LT | 2 |
Cagiannos, I | 2 |
Morash, C | 2 |
Flaman, A | 1 |
Breau, RH | 2 |
Varady, NH | 1 |
Chen, AF | 1 |
Drayer, NJ | 1 |
Ready, J | 1 |
Lozano-Calderon, SA | 1 |
Hayden, BL | 1 |
Rampotas, A | 1 |
Watson, E | 1 |
Burton, K | 1 |
Hill, QA | 1 |
Pavord, S | 1 |
Fergusson, NA | 1 |
Cnossen, S | 1 |
Geist, MJP | 1 |
Kessler, J | 1 |
Frankenhauser, S | 1 |
Bardenheuer, HJ | 1 |
Hankerson, MJ | 1 |
Raffetto, B | 1 |
Mallon, WK | 1 |
Shoenberger, JM | 1 |
Zamani, A | 1 |
Laurentaci, G | 2 |
Tatò, FB | 2 |
Dunbar, SD | 1 |
Ornstein, DL | 1 |
Zacharski, LR | 1 |
Fosså, SD | 1 |
Solheim, O | 1 |
Fosså, J | 1 |
Høst, H | 1 |
Rutqvist, LE | 1 |
Bolund, C | 1 |
Friberg, S | 1 |
Einhorn, N | 1 |
Wallgren, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prophylactic Topical Epinephrine to Reduce Transbronchial Lung Biopsy-related Hemorrhage in Lung Transplant Recipients: a Prospective Double-blind Placebo-controlled Trial (PROPHylactic Epinephrine in Transbronchial Biopsy [PROPHET] Trial)[NCT03126968] | Phase 2/Phase 3 | 100 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for tranexamic acid and Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Incidence of Thromboembolic Events in Oncology Patients Receiving Intraoperative Tranexamic Acid During Orthopedic Surgery: A Retrospective Review at a Comprehensive Cancer Center.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Humans; Incidence; Intraoperativ | 2020 |
The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Adult; Aminocaproic Acid; Blood Loss, Surgical; Blood Transfusion; Erythrocyte Transfusion; Humans; | 2017 |
Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin.
Topics: Amiloride; Animals; Antineoplastic Agents; Aprotinin; Diuretics; Fibrinolysin; Humans; Neoplasms; Se | 2000 |
2 trials available for tranexamic acid and Neoplasms
Article | Year |
---|---|
Preoperative tranexamic acid does not reduce transfusion rates in major oncologic surgery: Results of a randomized, double-blind, and placebo-controlled trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Female; Follo | 2020 |
[Cyklokapron (tranexamic acid) in the treatment of patients with advanced neoplasms].
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Eval | 1978 |
11 other studies available for tranexamic acid and Neoplasms
Article | Year |
---|---|
Tourniquet use in patients undergoing tumour resection and endoprosthetic reconstruction of the knee.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Humans; Knee Joint; Neoplasms; Tourniquets; | 2022 |
Lysine analogue use during cancer surgery: a survey from a Canadian tertiary care centre.
Topics: Aminocaproic Acid; Blood Loss, Surgical; Humans; Lysine; Neoplasms; Ontario; Surveys and Questionnai | 2020 |
Tranexamic acid in patients with current or former cancer undergoing hip and knee arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Fema | 2021 |
A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Combined M | 2022 |
Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid.
Topics: Aged, 80 and over; Antifibrinolytic Agents; Female; Germany; Hemorrhage; Humans; Male; Middle Aged; | 2017 |
Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis.
Topics: Antifibrinolytic Agents; Hemoptysis; Humans; Nebulizers and Vaporizers; Neoplasms; Palliative Care; | 2015 |
Bronchoscopic intratumoral injection of tranexamic acid: a new technique for control of biopsy-induced bleeding.
Topics: Adult; Biopsy; Bronchoscopy; Hemorrhage; Humans; Injections, Intralesional; Male; Methods; Middle Ag | 2011 |
[Possibilities of immunostimulation in oncology. I. In vitro functional activity of rat peritoneal macrophages in presence of tranexamic acid].
Topics: Adjuvants, Immunologic; Animals; Ascitic Fluid; Cells, Cultured; Cyclohexanecarboxylic Acids; In Vit | 1980 |
[Possibilities of immunostimulation in oncology. II. Activation of peritoneal macrophages of rats treated with tranexamic acid].
Topics: Animals; Ascitic Fluid; Cells, Cultured; Cyclohexanecarboxylic Acids; Immunotherapy; Macrophages; Ne | 1980 |
[Cyklokapron in the treatment of neoplasms].
Topics: Cyclohexanecarboxylic Acids; Humans; Neoplasms; Tranexamic Acid | 1978 |
[Treatment of advanced cancer with Cyclocapron (tranexamic acid)].
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Cyclohexanecarboxylic Acids; Female; Humans; Melanoma | 1977 |